Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with Rare Diseases
Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…
Save
Share
Rare Disease Strategies in the Booming US Market
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the most salient issue at the nexus of…
Save
Share
Pierre Morneau – General Manager, Takeda Switzerland
Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access, the Swiss framework for rare…
Save
Share
Stephen Farr – President & CEO, Zogenix
Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into…
Save
Share
Ramona Sequeira – President, Takeda Pharmaceuticals USA;…
Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the crucial importance of investing in…
Save
Share
Bradley Campbell – President & COO, Amicus…
Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches, the company’s first steps into…
Save
Share
Katharina Gasser – Managing Director, Biogen Switzerland…
Biogen Switzerland’s Dr Katharina Gasser outlines how the company’s 100 percent commitment to neuroscience helps it to stand apart, why…
Save
Share
Peter L. Saltonstall – President & CEO, National…
Ahead of the 2020 US National Organization for Rare Disorders (NORD)’s Rare Diseases and Orphan Products Breakthrough Summit, NORD president and CEO…
Save
Share
Paying for Cell & Gene Therapy in the USA: Is the Future…
Certara’s Ulrich Neumann looks at the challenges that payment models for cell and gene therapy (CGT) have faced, the multiple models now under…
Save
Share
Gary Zieziula – President & Region Head North America,…
Gary Zieziula, president & region head North America for Kyowa Kirin, a specialty care-focused Japan-based global pharma company, highlights the…
Save
Share
Kevin Houdenaert – General Manager, Recordati Benelux…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care specialist Recordati, gives an…
Save
Share
William H Lewis – Chairman & CEO, Insmed
William H Lewis, chairman and CEO of serious and rare disease specialist Insmed, talks through the impact of recent product approvals in the US,…
Save
Share
Page: 1 |
1
2
3
4
5
6
7
8
9
10
interviews
{"post_type":["article","interviews","legal_article","facts","infocus","sponsored"],"post_status":"publish","posts_per_page":12,"max_num_pages":-1,"paged":1,"meta_query":[{"key":"related","value":"Rare Diseases","compare":"LIKE"}]}
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT